ArticleJournal for immunotherapy of cancer2022

Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate.

Rosemina Merchant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.